🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Nuvation Bio Inc.

NUVB Healthcare
$5.68 +$0.07 (1.25%)
Market Cap: $1.98 B
Gurus Holding
7
Popularity Rank
#1223
% of Shares Held
2.49%
Net Activity (Q1 2026)
+$13.13 M

Guru Ownership Trend

Guru Analysis for Nuvation Bio Inc. (NUVB)

Nuvation Bio Inc. (NUVB), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $49.32 M.

Top institutional holders include Stanley Druckenmiller and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $13.13 M net inflow during the quarter.

Recent activity highlights Stanley Druckenmiller who opened a new position. Conversely, David Abrams reduced exposure by 66.7%.

Key Holders

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$24.49 M
Total Buy Value
New Buys 4
Additions 1
-$11.36 M
Total Sell Value
Reductions 1
Sold Out 2

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
3
Net Buyers
5

FAQs for Nuvation Bio Inc. (NUVB)

Major holders include Stanley Druckenmiller ($19.48 M), Cliff Asness ($8.56 M), David Abrams ($5.45 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 8.68 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $13.13 M, with 5 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited NUVB. The total reported sell value was $11.36 M.

Yes, 4 managers opened new positions in NUVB, and 1 increased their existing holdings. The total reported buy value was $24.49 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.58% New Buy 4,539,800 $19.48 M Q1 2026
0.00% Add 19.6% 1,995,758 $8.56 M Q1 2026
0.12% Reduce -66.7% 1,270,504 $5.45 M Q1 2026
0.00% New Buy 559,180 $2.4 M Q1 2026
0.00% New Buy 177,260 $760,445 Q1 2026
0.10% New Buy 105,000 $450,450 Q1 2026
0.00% 34,995 $150,129 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form